Mydecine Innovations Group Inc.
MYCO
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 44.50K | 9.90K | 15.00K | 28.50K | 12.80K |
| Total Receivables | 87.40K | 105.90K | 128.30K | 117.70K | 74.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 14.20K | 14.60K | 2.84M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 132.00K | 115.80K | 157.60K | 160.80K | 2.93M |
|
|
|||||
| Total Current Assets | 132.00K | 115.80K | 157.60K | 160.80K | 2.93M |
| Net Property, Plant & Equipment | -- | -- | -- | 0.00 | 0.00 |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | 362.70K |
| Total Assets | 132.00K | 115.80K | 157.60K | 160.80K | 3.29M |
|
|
|||||
| Total Accounts Payable | 5.26M | 4.29M | 3.13M | 3.15M | 2.38M |
| Total Accrued Expenses | 2.95M | 2.63M | 2.25M | 1.93M | 1.67M |
| Short-term Debt | 168.50K | 163.90K | 161.50K | 158.60K | 65.10K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.66M | 4.33M | 4.10M | 3.95M | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 13.05M | 11.41M | 9.64M | 9.18M | 4.11M |
|
|
|||||
| Total Current Liabilities | 13.05M | 11.41M | 9.64M | 9.18M | 4.11M |
| Long-Term Debt | -- | -- | -- | -- | 4.00M |
| Short-term Debt | 168.50K | 163.90K | 161.50K | 158.60K | 65.10K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.05M | 11.41M | 9.64M | 9.18M | 8.11M |
|
|
|||||
| Common Stock & APIC | 105.89M | 104.52M | 105.61M | 108.21M | 104.83M |
| Retained Earnings | -119.02M | -116.02M | -115.30M | -117.45M | -109.78M |
| Treasury Stock & Other | 211.50K | 208.80K | 211.00K | 216.40K | 129.90K |
| Total Common Equity | -12.91M | -11.29M | -9.48M | -9.02M | -4.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.91M | -11.29M | -9.48M | -9.02M | -4.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.91M | -11.29M | -9.48M | -9.02M | -4.82M |
|
|
|||||
